[{"address1": "12278 Scripps Summit Drive", "city": "San Diego", "state": "CA", "zip": "92131", "country": "United States", "phone": "858 875 1800", "website": "https://www.fatetherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.", "fullTimeEmployees": 181, "companyOfficers": [{"maxAge": 1, "name": "Dr. Bahram  Valamehr M.B.A., Ph.D.", "age": 47, "title": "President, CEO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 676600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cindy R. Tahl J.D.", "age": 51, "title": "Chief Legal & Compliance Officer and Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 644600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Victor  Hong", "title": "Vice President of Corporate Development & Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessica  Francis", "title": "Vice President Of Human Resources & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Henry", "age": 60, "title": "Senior Vice President of Clinical Operations", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tunde  Babalola", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yu  Cai", "title": "Head of Intellectual Property & Assistant General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  Duvall", "title": "Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 3, "boardRisk": 3, "compensationRisk": 5, "shareHolderRightsRisk": 10, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.07, "open": 1.09, "dayLow": 1.08, "dayHigh": 1.155, "regularMarketPreviousClose": 1.07, "regularMarketOpen": 1.09, "regularMarketDayLow": 1.08, "regularMarketDayHigh": 1.155, "payoutRatio": 0.0, "beta": 2.245, "forwardPE": -0.64880955, "volume": 1659985, "regularMarketVolume": 1659985, "averageVolume": 1717345, "averageVolume10days": 1619170, "averageDailyVolume10Day": 1619170, "bid": 1.05, "ask": 1.13, "bidSize": 1, "askSize": 1, "marketCap": 125709704, "fiftyTwoWeekLow": 0.66, "fiftyTwoWeekHigh": 4.2, "priceToSalesTrailing12Months": 14.84176, "fiftyDayAverage": 1.1756, "twoHundredDayAverage": 1.4253, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -15786630, "profitMargins": 0.0, "floatShares": 92866932, "sharesOutstanding": 115330000, "sharesShort": 9279254, "sharesShortPriorMonth": 9544385, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0809, "heldPercentInsiders": 0.01706, "heldPercentInstitutions": 0.78626996, "shortRatio": 6.34, "shortPercentOfFloat": 0.0924, "impliedSharesOutstanding": 115330000, "bookValue": 2.28, "priceToBook": 0.4780702, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -171522000, "trailingEps": -1.46, "forwardEps": -1.68, "enterpriseToRevenue": -1.864, "enterpriseToEbitda": 0.098, "52WeekChange": -0.69972456, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 1.09, "targetHighPrice": 12.0, "targetLowPrice": 2.0, "targetMeanPrice": 5.45, "targetMedianPrice": 5.0, "recommendationMean": 2.38462, "recommendationKey": "buy", "numberOfAnalystOpinions": 10, "totalCash": 222830000, "totalCashPerShare": 1.932, "ebitda": -161604992, "totalDebt": 81331000, "quickRatio": 7.89, "currentRatio": 8.035, "totalRevenue": 8470000, "debtToEquity": 31.118, "revenuePerShare": 0.072, "returnOnAssets": -0.24659, "returnOnEquity": -0.52107, "grossProfits": -106806000, "freeCashflow": -60912500, "operatingCashflow": -115614000, "revenueGrowth": -0.718, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -19.38542, "financialCurrency": "USD", "symbol": "FATE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1380634200000, "postMarketChangePercent": 4.5871515, "shortName": "Fate Therapeutics, Inc.", "longName": "Fate Therapeutics, Inc.", "postMarketPrice": 1.14, "postMarketChange": 0.049999952, "regularMarketChange": 0.02, "regularMarketDayRange": "1.08 - 1.155", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1717345, "fiftyTwoWeekLowChange": 0.43, "fiftyTwoWeekLowChangePercent": 0.6515151, "fiftyTwoWeekRange": "0.66 - 4.2", "fiftyTwoWeekHighChange": -3.1099997, "fiftyTwoWeekHighChangePercent": -0.74047613, "fiftyTwoWeekChangePercent": -69.97246, "earningsTimestampStart": 1762891200, "earningsTimestampEnd": 1762891200, "earningsCallTimestampStart": 1715288400, "earningsCallTimestampEnd": 1715288400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.46, "epsForward": -1.68, "epsCurrentYear": -1.1119, "priceEpsCurrentYear": -0.98030406, "fiftyDayAverageChange": -0.08560002, "fiftyDayAverageChangePercent": -0.0728139, "twoHundredDayAverageChange": -0.33529997, "twoHundredDayAverageChangePercent": -0.2352487, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.4 - Buy", "cryptoTradeable": false, "regularMarketChangePercent": 1.86916, "regularMarketPrice": 1.09, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1755302367, "regularMarketTime": 1755288001, "exchange": "NGM", "messageBoardId": "finmb_39268712", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Fate Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]